However, unlike monogenic autoinflammatory diseases such as cryopyrin‐associated periodic syndrome (CAPS), a straightforward treatment such as IL‐1 blockade is not consistently effective for PSTPIP1‐associated conditions. Here, IL1B is linked to cryopyrin-associated periodic syndrome.